MindMaze

MindMaze is a Swiss neurotechnology company developing VR-based neurorehabilitation platforms and BCI-enabled therapeutic systems. The company achieved unicorn status in 2016 after a $100M investment from the Hinduja Group and raised $105M in February 2022. MindMaze's core platform combines real-time motion capture, virtual reality, and neural feedback to accelerate motor recovery following stroke and traumatic brain injury. In 2025, MindMaze merged with Relief Therapeutics to form MindMaze Therapeutics Holding, which now trades publicly under ticker MMTX with revenue of $24.1M.